We're rethinking urologic catheters.

Better flow. Better Outcome. Better Lives.
Learn How

Catheter-Associated Urinary Tract Infections (CAUTI) are a Big Problem

CAUTI rates can exceed 90% and kill thousands
The nine problems that motivate us.
The CAUTI Problem

The Solution

The Blue Halo catheter reduces infection rates by over 80%*

Unlike other catheters, Blue Halo's proprietary devices do not require an external collection device, reduce the CAUTI Rate, and improve the quality of life in Urologic patients. Blue Halo’s catheters have a superior flow rate, which, in clinical tests, reduces infection rates by over 80%.
About Us

Our Team

The background and knowledge to make a difference.
Anthony Ruben
Chief Executive Officer
Completed over $2+ billion in transactions in healthcare, software and technology.
Dr. Byron Hodge, Jr. MD
Director of Clinical Development
Urologic oncologist and principle urological researcher
Dr. Gaines Hammond, Jr. MD FACS
Chairman of the Board
Board-certified urologic surgeon and regulatory process veteran.
Rogers Kirven, Jr.
Director of Business Development
Over 50+ private equity investments in the past 25 years
Learn More
Signup for news, updates and early announcements.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is a secure form, we'll never share, sell or SPAM your email.